These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 953935)

  • 1. Restaging of breast cancer in a northern Alberta registry.
    Burns PE; Kredentser S; Grace M
    Can Med Assoc J; 1976 Sep; 115(6):516-8. PubMed ID: 953935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].
    Katalinic A; Holzmann M; Kunze U
    Gesundheitswesen; 2003; 65(8-9):509-15. PubMed ID: 14505270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.
    Güven HE; Bulak H; Turanli S; Oral S
    Singapore Med J; 2007 Jan; 48(1):31-3. PubMed ID: 17245513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer in northern Alberta: pilot study in computerized registration.
    Burns PE; Kredentser J; Grace M; Hanson J
    Can Med Assoc J; 1977 May; 116(10):1131-5. PubMed ID: 861863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
    Duraker N; Caynak ZC
    Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an appropriate staging system for esophageal carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of conservative treatment of stage I-II carcinoma of the breast. Analysis of 311 patients].
    Antonello M; Polico R; Busetto M; Pizzi G
    Radiol Med; 1992 Oct; 84(4):440-3. PubMed ID: 1455028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proposals for revisions of UICC TNM system (1997)--breast cancer].
    Yamamoto H; Morimoto T; Sano M; Fukuda M; Ueno E; Tajima T; Iwase T
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1087-93. PubMed ID: 9644326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of minute axillary lymph nodes to accurate staging for patients with breast cancer.
    Jiang J; He QQ; Yang XH; Liang Y; Fan LJ; Zhang Y; Guo MQ
    Chin Med J (Engl); 2007 Oct; 120(20):1762-5. PubMed ID: 18028767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comments on the new American Joint Committee on Cancer TNM staging for breast cancer. What's new for the pathologist?].
    Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):492-5. PubMed ID: 15094587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
    Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B
    Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.